富士製薬工業(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4554/E00975 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/12/29 | 日証協 | 71,003株 | -22.72% | 17,003株 | +151.6% | 25,834株 | -34.15% | 18,900株 | +656% |
| 2017/12/22 | 日証協 | 91,882株 | -3.12% | 6,758株 | -84.64% | 39,234株 | +7.1% | 2,500株 | -28.59% |
| 2017/12/15 | 日証協 | 94,845株 | +23.91% | 44,006株 | +19.96% | 36,634株 | -6.38% | 3,501株 | -62.34% |
| 2017/12/08 | 日証協 | 76,542株 | +2.27% | 36,683株 | +49.43% | 39,130株 | -6.91% | 9,297株 | -43.99% |
| 2017/12/01 | 日証協 | 74,845株 | -11.76% | 24,548株 | -12.07% | 42,033株 | +22.43% | 16,600株 | +42.93% |
| 2017/11/24 | 日証協 | 84,817株 | -4.07% | 27,917株 | +29.64% | 34,333株 | -4.98% | 11,614株 | -30.87% |
| 2017/11/17 | 日証協 | 88,417株 | +6.78% | 21,534株 | +121.93% | 36,133株 | +33.65% | 16,800株 | +90.91% |
| 2017/11/10 | 日証協 | 82,803株 | -5.37% | 9,703株 | -11.81% | 27,035株 | +1.5% | 8,800株 | +576.92% |
| 2017/11/02 | 日証協 | 87,503株 | +7.21% | 11,003株 | -64.64% | 26,635株 | +3.9% | 1,300株 | -53.6% |
| 2017/10/27 | 日証協 | 81,617株 | +16.43% | 31,117株 | +469.49% | 25,635株 | -5.17% | 2,802株 | -12.44% |
| 2017/10/20 | 日証協 | 70,100株 | +18.61% | 5,464株 | -74.7% | 27,033株 | -6.58% | 3,200株 | +60% |
| 2017/10/13 | 日証協 | 59,100株 | +8.84% | 21,600株 | -50.46% | 28,936株 | -4.61% | 2,000株 | -33.42% |
| 2017/10/06 | 日証協 | 54,300株 | +227.98% | 43,600株 | -73.51% | 30,333株 | +31.85% | 3,004株 | -94.21% |
| 2017/09/29 | 日証協 | 16,556株 | -85.41% | 164,600株 | +1135.55% | 23,006株 | -88.67% | 51,900株 | +517.12% |
| 2017/09/22 | 日証協 | 113,500株 | -3.07% | 13,322株 | +107.99% | 203,008株 | -3.79% | 8,410株 | +425.62% |
| 2017/09/15 | 日証協 | 117,100株 | -0.69% | 6,405株 | -42.11% | 211,016株 | -2.13% | 1,600株 | -95.63% |
| 2017/09/08 | 日証協 | 117,915株 | +0.27% | 11,064株 | +7.82% | 215,616株 | +15.11% | 36,600株 | +441.74% |
| 2017/09/01 | 日証協 | 117,603株 | -6.55% | 10,262株 | +41.62% | 187,316株 | -0.69% | 6,756株 | +121.65% |
| 2017/08/25 | 日証協 | 125,846株 | -3.2% | 7,246株 | -62.49% | 188,616株 | -1.1% | 3,048株 | -68.62% |
※株式分割は考慮していませんのでご注意ください。
Page Top